GlassScriptPhysician profile
Brian S Barnett
NPI 1346688421
$20,813.55
in general payments reported to CMS, 2019-2025
7 companies · $7,397 in 2025
The $7,397 reported for 2025 was more than what 95% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $13K · 2025: $7,397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,000 · Travel and Lodging: $2,588 · Food and Beverage: $1,313 · Education: $27.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,885.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,000.00 |
| Travel and Lodging | $2,588.40 |
| Food and Beverage | $1,312.88 |
| Education | $27.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $12,426.94 | 2024 | Spravato, Invega Sustenna, Invega Trinza |
| Abbvie INC. | $7,375.00 | 2025 | |
| Livanova USA, INC. | $962.20 | 2024 | Vns Therapy Symmetry Model 8103 Generator |
| E.R. Squibb & Sons, L.L.C. | $27.27 | 2024 | Cobenfy |
| Tms Neurohealth Centers INC. | $16.00 | 2025 | Tms Neurohealth Centers INC. |
| Neurocrine Biosciences, INC. | $6.14 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Barnett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.